ALLO · Allogene Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| David D. Chang President and CEO | ▼ Sell | Open Market | 5,150,599 Shares held | 3/16/2026 | View profile |
| Belldegrun Arie Director | ▲ Buy | Grant | 2,236,816 Shares held | 1/24/2025 | View profile |
| Geoffrey M. Parker Director | ▼ Sell | Open Market | 1,252,795 Shares held | 2/2/2026 | View profile |
| SCHMIDT ERIC THOMAS Director | ▲ Buy | Grant | 862,439 Shares held | 3/22/2023 | View profile |
| Alison Moore Director | ▲ Buy | Grant | 672,731 Shares held | 3/22/2023 | View profile |
| Zachary Roberts EVP of R&D | ▼ Sell | Open Market | 581,166 Shares held | 2/2/2026 | View profile |
| Bhavnagri Veer General Counsel | ▼ Sell | Tax Withholding | 556,049 Shares held | 3/14/2023 | View profile |
| Rafael Amado EVP of R&D and CMO | ▼ Sell | Tax Withholding | 541,946 Shares held | 10/7/2022 | View profile |
| Earl Martin Douglas SVP, General Counsel | ▼ Sell | Open Market | 488,267 Shares held | 8/21/2026 | View profile |
| Joshua A. Kazam Director | ▲ Buy | Option Exercise | 398,463 Shares held | 6/18/2026 | View profile |
| Humer Franz B | ▼ Sell | Open Market | 307,507 Shares held | 12/5/2024 | View profile |
| WITTE OWEN N. | ▲ Buy | Grant | 292,832 Shares held | 6/13/2023 | View profile |
| Timothy L. Moore Director | ▼ Sell | Open Market | 250,713 Shares held | 2/3/2025 | View profile |
| Benjamin Machinas Beneski SVP, Chief Technical Officer | ▼ Sell | Open Market | 195,338 Shares held | 3/31/2026 | View profile |
| Vicki L. Sato Director | ▲ Buy | Grant | 162,575 Shares held | 6/5/2024 | View profile |
| Smith Lillian VP, Corporate Counsel | ▲ Buy | Grant | 140,390 Shares held | 4/1/2023 | View profile |
| Annie Yoshiyama SVP, Finance | ▼ Sell | Open Market | 124,517 Shares held | 4/21/2026 | View profile |
| Deborah M. Messemer Director | ▼ Sell | Open Market | 107,431 Shares held | 6/10/2025 | View profile |
| CHEN YINLIN JACK SVP, Finance | ▲ Buy | Grant | 88,881 Shares held | 8/10/2023 | View profile |
| Stephen Mayo Director | ▼ Sell | Open Market | 25,328 Shares held | 8/7/2023 | View profile |
| PF Equity Holdings 2 B.V. 10% Owner | ▼ Sell | Other | 0 Shares held | 3/31/2022 | View profile |
Transaction History
| Earl Martin Douglas | ▼ Sell | Open Market | 29,697 | $63K | 8/21/2026 |
| Joshua A. Kazam | ▲ Buy | Option Exercise | 47,700 | $0 | 6/18/2026 |
| Annie Yoshiyama | ▼ Sell | Open Market | 9,586 | $22K | 4/21/2026 |
| Benjamin Machinas Beneski | ▼ Sell | Open Market | 2,867 | $7K | 3/31/2026 |
| David D. Chang | ▼ Sell | Open Market | 47,763 | $118K | 3/16/2026 |
| Benjamin Machinas Beneski | ▼ Sell | Open Market | 4,835 | $12K | 3/16/2026 |
| Benjamin Machinas Beneski | ▼ Sell | Open Market | 7,132 | $19K | 3/2/2026 |
| Benjamin Machinas Beneski | ▼ Sell | Open Market | 7,549 | $13K | 2/2/2026 |
| David D. Chang | ▼ Sell | Open Market | 95,269 | $171K | 2/2/2026 |
| Geoffrey M. Parker | ▼ Sell | Open Market | 24,001 | $42K | 2/2/2026 |
| Earl Martin Douglas | ▼ Sell | Open Market | 22,900 | $40K | 2/2/2026 |
| Annie Yoshiyama | ▼ Sell | Open Market | 4,167 | $7K | 2/2/2026 |
| Zachary Roberts | ▼ Sell | Open Market | 35,700 | $63K | 2/2/2026 |
| Zachary Roberts | ▼ Sell | Open Market | 26,269 | $41K | 1/21/2026 |
| Joshua A. Kazam | ▲ Buy | Option Exercise | 47,700 | $0 | 12/18/2025 |
| Benjamin Machinas Beneski | ▼ Sell | Open Market | 786 | $959 | 11/17/2025 |
| Geoffrey M. Parker | ▼ Sell | Open Market | 36,744 | $46K | 10/21/2025 |
| Deborah M. Messemer | ▼ Sell | Open Market | 36,885 | $52K | 6/10/2025 |
| Annie Yoshiyama | ▼ Sell | Open Market | 9,601 | $14K | 4/21/2025 |
| David D. Chang | ▼ Sell | Open Market | 46,668 | $91K | 3/14/2025 |
| Benjamin Machinas Beneski | ▼ Sell | Open Market | 5,488 | $11K | 3/14/2025 |
| Benjamin Machinas Beneski | ▲ Buy | Grant | 31,755 | $0 | 3/1/2025 |
| Deborah M. Messemer | ▼ Sell | Open Market | 13,313 | $32K | 2/18/2025 |
| Earl Martin Douglas | ▼ Sell | Open Market | 6,404 | $11K | 2/3/2025 |
| Geoffrey M. Parker | ▼ Sell | Open Market | 4,361 | $8K | 2/3/2025 |
| Timothy L. Moore | ▼ Sell | Open Market | 14,746 | $25K | 2/3/2025 |
| David D. Chang | ▼ Sell | Open Market | 46,003 | $77K | 2/3/2025 |
| Zachary Roberts | ▼ Sell | Open Market | 18,832 | $32K | 2/3/2025 |
| Earl Martin Douglas | ▲ Buy | Grant | 144,928 | $0 | 1/24/2025 |
| Geoffrey M. Parker | ▲ Buy | Grant | 173,913 | $0 | 1/24/2025 |
| Annie Yoshiyama | ▲ Buy | Grant | 36,232 | $0 | 1/24/2025 |
| Zachary Roberts | ▲ Buy | Grant | 173,913 | $0 | 1/24/2025 |
| Belldegrun Arie | ▲ Buy | Grant | 369,957 | $0 | 1/24/2025 |
| David D. Chang | ▲ Buy | Grant | 552,174 | $0 | 1/24/2025 |
| Zachary Roberts | ▼ Sell | Open Market | 27,199 | $48K | 1/21/2025 |
| Deborah M. Messemer | ▼ Sell | Open Market | 9,136 | $20K | 12/9/2024 |
| Humer Franz B | ▼ Sell | Open Market | 9,221 | $20K | 12/5/2024 |
| Geoffrey M. Parker | ▼ Sell | Tax Withholding | 36,404 | $103K | 10/21/2024 |
| Earl Martin Douglas | ▼ Sell | Tax Withholding | 28,310 | $79K | 8/21/2024 |
| Deborah M. Messemer | ▼ Sell | Open Market | 18,641 | $42K | 6/18/2024 |
| Vicki L. Sato | ▲ Buy | Grant | 61,475 | $0 | 6/5/2024 |
| Humer Franz B | ▲ Buy | Grant | 61,475 | $0 | 6/5/2024 |
| Deborah M. Messemer | ▲ Buy | Grant | 122,950 | $0 | 6/5/2024 |
| Humer Franz B | ▼ Sell | Open Market | 11,200 | $26K | 5/30/2024 |
| Belldegrun Arie | ▲ Buy | Grant | 344,828 | $1.0M | 5/16/2024 |
| Belldegrun Arie | ▲ Buy | Open Market | 1,724,137 | $5.0M | 5/16/2024 |
| Geoffrey M. Parker | ▲ Buy | Grant | 344,828 | $1.0M | 5/16/2024 |
| David D. Chang | ▲ Buy | Grant | 344,828 | $1.0M | 5/16/2024 |
| Timothy L. Moore | ▼ Sell | Tax Withholding | 17,360 | $60K | 4/22/2024 |
| David D. Chang | ▼ Sell | Tax Withholding | 53,393 | $231K | 3/14/2024 |
| Geoffrey M. Parker | ▲ Buy | Open Market | 190 | $683 | 1/30/2024 |
| Geoffrey M. Parker | ▲ Buy | Grant | 29,400 | $0 | 1/25/2024 |
| Belldegrun Arie | ▲ Buy | Grant | 211,973 | $0 | 1/25/2024 |
| Zachary Roberts | ▲ Buy | Grant | 140,000 | $0 | 1/25/2024 |
| David D. Chang | ▲ Buy | Grant | 317,800 | $0 | 1/25/2024 |
| Timothy L. Moore | ▲ Buy | Grant | 96,600 | $0 | 1/25/2024 |
| Earl Martin Douglas | ▲ Buy | Grant | 41,800 | $0 | 1/25/2024 |
| Zachary Roberts | ▼ Sell | Tax Withholding | 24,690 | $78K | 1/22/2024 |
| Deborah M. Messemer | ▼ Sell | Open Market | 18,640 | $50K | 12/18/2023 |
| Geoffrey M. Parker | ▲ Buy | Grant | 390,000 | $0 | 10/16/2023 |
| Geoffrey M. Parker | ▲ Buy | Grant | 400,000 | $0 | 10/16/2023 |
| Earl Martin Douglas | ▲ Buy | Grant | 108,958 | $0 | 8/14/2023 |
| Earl Martin Douglas | ▲ Buy | Grant | 326,876 | $0 | 8/14/2023 |
| CHEN YINLIN JACK | ▲ Buy | Grant | 11,401 | $0 | 8/10/2023 |
| Stephen Mayo | ▼ Sell | Open Market | 10,000 | $43K | 8/7/2023 |
| Deborah M. Messemer | ▲ Buy | Grant | 74,561 | $0 | 6/13/2023 |
| Vicki L. Sato | ▲ Buy | Grant | 59,649 | $0 | 6/13/2023 |
| Humer Franz B | ▲ Buy | Grant | 74,561 | $0 | 6/13/2023 |
| WITTE OWEN N. | ▲ Buy | Grant | 74,561 | $0 | 6/13/2023 |
| Timothy L. Moore | ▲ Buy | Grant | 186,219 | $0 | 4/24/2023 |
| Smith Lillian | ▲ Buy | Grant | 56,545 | $0 | 4/1/2023 |
| SCHMIDT ERIC THOMAS | ▲ Buy | Grant | 558,094 | $0 | 3/22/2023 |
| Zachary Roberts | ▲ Buy | Grant | 148,035 | $0 | 3/22/2023 |
| Belldegrun Arie | ▲ Buy | Grant | 1,282,976 | $0 | 3/22/2023 |
| David D. Chang | ▲ Buy | Grant | 1,924,464 | $0 | 3/22/2023 |
| Alison Moore | ▲ Buy | Grant | 558,094 | $0 | 3/22/2023 |
| David D. Chang | ▼ Sell | Tax Withholding | 22,340 | $124K | 3/14/2023 |
| SCHMIDT ERIC THOMAS | ▼ Sell | Tax Withholding | 35,879 | $196K | 3/14/2023 |
| Alison Moore | ▼ Sell | Tax Withholding | 8,351 | $46K | 3/14/2023 |
| Bhavnagri Veer | ▼ Sell | Tax Withholding | 23,628 | $134K | 3/14/2023 |
| Bhavnagri Veer | ▼ Sell | Open Market | 3,000 | $21K | 2/13/2023 |
| Zachary Roberts | ▲ Buy | Grant | 251,908 | $0 | 1/20/2023 |
| Bhavnagri Veer | ▼ Sell | Open Market | 3,000 | $21K | 1/17/2023 |
| Bhavnagri Veer | ▼ Sell | Open Market | 5,602 | $42K | 12/15/2022 |
| Rafael Amado | ▲ Buy | Grant | 19,120 | $0 | 10/7/2022 |
| Rafael Amado | ▼ Sell | Tax Withholding | 8,464 | $100K | 10/7/2022 |
| Rafael Amado | ▼ Sell | Tax Withholding | 8,968 | $99K | 10/3/2022 |
| WITTE OWEN N. | ▼ Sell | Open Market | 5,000 | $86K | 8/12/2022 |
| WITTE OWEN N. | ▼ Sell | Open Market | 5,000 | $86K | 8/12/2022 |
| WITTE OWEN N. | ▼ Sell | Open Market | 10,000 | $165K | 8/11/2022 |
| WITTE OWEN N. | ▼ Sell | Open Market | 10,000 | $165K | 8/11/2022 |
| Rafael Amado | ▼ Sell | Open Market | 2,000 | $24K | 8/2/2022 |
| Stephen Mayo | ▲ Buy | Grant | 35,328 | $0 | 7/8/2022 |
| Rafael Amado | ▼ Sell | Open Market | 2,000 | $23K | 7/5/2022 |
| WITTE OWEN N. | ▼ Sell | Open Market | 10,000 | $118K | 6/22/2022 |
| Rafael Amado | ▼ Sell | Open Market | 2,000 | $22K | 6/21/2022 |
| WITTE OWEN N. | ▲ Buy | Grant | 22,089 | $0 | 6/15/2022 |
| Humer Franz B | ▲ Buy | Grant | 44,178 | $0 | 6/15/2022 |
| Vicki L. Sato | ▲ Buy | Grant | 22,089 | $0 | 6/15/2022 |
| Joshua A. Kazam | ▲ Buy | Grant | 44,178 | $0 | 6/15/2022 |
| Rafael Amado | ▼ Sell | Open Market | 11,500 | $85K | 5/19/2022 |
| PF Equity Holdings 2 B.V. | ▼ Sell | Other | 22,032,040 | $0 | 3/31/2022 |
| Rafael Amado | ▲ Buy | Grant | 237,358 | $0 | 3/23/2022 |
| Bhavnagri Veer | ▲ Buy | Grant | 175,438 | $0 | 3/23/2022 |
| SCHMIDT ERIC THOMAS | ▲ Buy | Grant | 237,358 | $0 | 3/23/2022 |
| David D. Chang | ▼ Sell | Open Market | 23,648 | $181K | 3/15/2022 |
| SCHMIDT ERIC THOMAS | ▼ Sell | Open Market | 11,469 | $88K | 3/15/2022 |
| Alison Moore | ▼ Sell | Open Market | 8,698 | $66K | 3/15/2022 |
| Bhavnagri Veer | ▼ Sell | Open Market | 8,849 | $68K | 3/15/2022 |
| Rafael Amado | ▼ Sell | Open Market | 5,169 | $40K | 3/15/2022 |
| Belldegrun Arie | ▼ Sell | Other | 4,710,121 | $0 | 3/14/2022 |
| Belldegrun Arie | ▼ Sell | Other | 4,710,121 | $0 | 3/14/2022 |
| Joshua A. Kazam | ▼ Sell | Gift | 412,618 | $0 | 3/7/2022 |
| Joshua A. Kazam | ▼ Sell | Other | 412,618 | $0 | 3/7/2022 |
| Belldegrun Arie | ▲ Buy | Open Market | 155,039 | $2.0M | 1/12/2022 |
| Joshua A. Kazam | ▲ Buy | Open Market | 15,000 | $189K | 1/12/2022 |
| Rafael Amado | ▼ Sell | Open Market | 11,507 | $280K | 10/1/2021 |
| Bhavnagri Veer | ▲ Buy | Option Exercise | 5,000 | $11K | 9/15/2021 |
| Bhavnagri Veer | ▼ Sell | Open Market | 5,000 | $124K | 9/15/2021 |
| WITTE OWEN N. | ▼ Sell | Open Market | 5,000 | $128K | 9/9/2021 |
| WITTE OWEN N. | ▼ Sell | Open Market | 5,000 | $119K | 8/20/2021 |
| WITTE OWEN N. | ▼ Sell | Open Market | 5,000 | $116K | 8/20/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Allogene CFO Departure Comes Amid CAR-T Sector Safety Concerns
Allogene announced that Chief Financial Officer Geoffrey Parker will retire effective November 6, marking a leadership transition at a challenging time for the company. The timing coincides with broader scrutiny of CAR-T therapies for autoimmune conditions after competing trials from Novartis and Bristol Myers were paused over safety concerns. On the clinical front, the company indicated that if its minimal residual disease data holds, it could represent a significant shift in its business outlook. The stock has traded within a $1.04 to $4.46 range over the past year.
Allogene CFO Departure Comes Amid CAR-T Sector Safety Concerns. Allogene announced that Chief Financial Officer Geoffrey Parker will retire effective November 6, marking a leadership transition at a challenging time for the company. The timing coincides with broader scrutiny of CAR-T therapies for autoimmune conditions after competing trials from Novartis and Bristol Myers were paused over safety concerns. On the clinical front, the company indicated that if its minimal residual disease data holds, it could represent a significant shift in its business outlook. The stock has traded within a $1.04 to $4.46 range over the past year.